A Novel Recombinant MAGE-B10-HSP110 Fusion Protein Enhances Innate and Adaptive Immune Responses in Mice: A Potential Vaccine Candidate for Canine Mammary Tumors.

Animals (Basel) · 2026 · PMC13163047 · PMID 42121790

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Conversely, the mean level of antibodies specific to canine MAGE-B10 in mice immunized with a mixture of rMAGE-B10 and rHSP110 with adjuvant showed an increasing trend at day 7 and continued to rise on days 14 and 21.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.